Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
5
56%
Ph phase_1
1
11%
Ph not_applicable
1
11%
Ph phase_3
2
22%

Phase Distribution

1

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(3)
Other(6)

Detailed Status

unknown6
Completed3

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 32 (22.2%)
Phase 45 (55.6%)
N/A1 (11.1%)

Trials by Status

completed333%
unknown667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9